L’Oreal has satisfied the Federal Circuit to partially reverse a district court docket ruling ordering it to pay $66 million for infringing two patents and stealing commerce secrets and techniques from cosmetics startup Olaplex.
The Federal Circuit discovered that the commerce secrets and techniques that the sweetness big was accused to have stolen from Olaplex have been “not secret” and known as for a retrial for the infringement of one of many patents in a non-precedential determination revealed yesterday, April 6.
Olaplex’s cross-appeal for non-patent damages was denied because of the Federal Circuit’s reversal of non-patent legal responsibility within the proceedings.
L’Oreal’s request to reassign proceedings to a distinct district court docket decide was additionally denied.
Action towards L’Oreal was first introduced by Liqwd, who had all of its curiosity transferred to fellow plaintiff Olaplex in January 2020.
In August 2019 a jury on the US District Court for the District of Delaware dominated in favour of Olaplex, discovering L’Oreal responsible of infringing two hair remedy patents (US9,498,419 and US9,668,954) and of misappropriation of a number of commerce secrets and techniques.
The jury decided that Olaplex was entitled to just about $100 million in damages. Judge Bataillon then dominated that Olaplex was solely entitled to $66.2 million in complete.
The decide additionally granted a everlasting injunction stopping L’Oreal from promoting the infringing ‘Smartbond’ merchandise.
The majority of claims of the 2 patents L’Oreal had been accused of infringing have been invalidated in earlier proceedings by the Patent Trial and Appeal Board (PTAB), leaving solely claims associated to strategies for decreasing ‘breakage’ from a single hair bleaching session.
The PTAB discovered claims 1–13, 19–23, and 29–30 of the Olaplex patent (US quantity 9,668,954) to be invalid as apparent.
L’Oreal USA appealed the district court docket ruling to the Federal Circuit and Olaplex filed a discover of cross-appeal.
In prior Federal Circuit proceedings, each L’Oréal and Olaplex did not persuade the court docket to overturn the choice associated to the patent therapies, upholding the PTAB determination which invalidated key claims of each the patents, however sustaining different claims of the patents have been nonetheless legitimate.
Did you take pleasure in studying this story? Sign as much as our free each day newsletters and get tales despatched like this straight to your inbox
Today’s high tales
Ericsson and Samsung agree SEP truce
US backs COVID IP waiver – Industry reacts
